Location: RM 271
State Agency Perspectives
OPIOID AND OTHER SUBSTANCE USE DISORDERS
|Votes: View-->||Action Taken:|
03:12 PM -- State Agency Perspectives
Lindsey Myers, CDPHE, presented to the committee and distributed a handout (Attachment N). She gave an overview of the CDPHE's multi-disciplinary approach to substance use. Ms. Myers described projects related to prescription drug abuse including funding from the Bureau of Justice Assistance to assist the consortium, a Centers for Disease Control grant for the PDMP, and the Medication Take Back Program. She summarized current CDPHE joint initiatives with other state agencies, county health departments, and providers and hospitals.
Ms. Myers discussed funding for provider education and an alcohol epidemiology grant. She went over efforts related to marijuana, and the Communities that Care program.
Mark Condojani, Colorado Department of Human Services, presented to the committee and referred to a previous handout (Attachment F). Mr. Condojani gave an overview of the substance use disorder services in Colorado, including treatment types, special organizations, and stakeholders. He summarized the medication-assisted treatment process, and explained how treatment facilities are licensed in Colorado. Mr. Condojani reviewed ongoing and planned DHS initiatives related to substance abuse treatment and recovery in Colorado.
Mr. Condojani responded to questions regarding residential treatment programs and detox centers. He discussed residential and outpatient treatment options for treatment and medical detox. Committee members commented on the role of the mental health institutes and the criminal justice system in opioid and substance use treatment.
Mr. Condojani discussed DHS family services and homeless services. He highlighted day-of-release services and other initiatives including stigma reduction, work with Native American tribes, and outreach.
Ronne Hines, Department of Regulatory Agencies (DORA), began her presentation and provide a handout (Attachment O) and pamphlets to the committee. She described the role of DORA in preventing prescription drug abuse, including administering the PDMP, partnering with the consortium, and implementing a policy for prescribing and dispensing opioids. Ms. Hines explained various updates and enhancements to the PDMP.